Bradbury A W, Brittenden J, McBride K, Ruckley C V
University Department of Surgery, Royal Infirmary, Edinburgh, UK.
Br J Surg. 1995 Nov;82(11):1446-59. doi: 10.1002/bjs.1800821105.
Mesenteric ischaemia may result from a wide range of pathological processes, each possessing unique clinical features, diagnostic difficulties, management strategies and outcome. Regardless of aetiology, prognosis depends crucially on rapid diagnosis and institution of treatment to prevent, or at least to minimize, bowel infarction. Progress in understanding the pathophysiology of mesenteric ischaemia has led to novel methods of treatment, so that in some circumstances therapy may be purely medical. More often surgery is required and is frequently life saving. Percutaneous transcatheter techniques are increasingly employed in both diagnosis and treatment. Close cooperation between radiologists, physicians and surgeons is therefore necessary if clinical outcome is to be optimized. This paper reviews the modern interdisciplinary management of mesenteric ischaemia in the light of recent advances.
肠系膜缺血可能由多种病理过程引起，每种病理过程都有其独特的临床特征、诊断难点、治疗策略及预后情况。无论病因如何，预后主要取决于能否快速诊断并开始治疗，以预防或至少尽量减少肠梗死。对肠系膜缺血病理生理学认识的进展催生了新的治疗方法，因此在某些情况下，治疗可能单纯依靠药物。但更多时候需要进行手术，且手术常常能挽救生命。经皮导管技术在诊断和治疗中应用得越来越多。因此，若要优化临床结果，放射科医生、内科医生和外科医生之间密切合作是必要的。本文根据最新进展综述了肠系膜缺血的现代多学科管理。
